The aim is to evaluate how ejection fraction influences the effectiveness of spironolactone in heart failure patients.
Observed patients with heart failure and preserved ejection fraction.
Administered spironolactone as treatment.
Monitored outcomes related to heart failure.
Analyzed the impact of ejection fraction on treatment response.
Identified varying outcomes based on ejection fraction levels.
Noted improved efficacy of spironolactone in specific ejection fraction ranges.
Provided insights for tailored treatment approaches.
Abstract
Nct00094302.
Ask AI
Helpful
Bookmark
Share
View Full Paper
Cite This Study
Solomon et al. (2015) studied this question. Increasing ejection fraction significantly correlates with improved clinical outcomes in heart failure patients treated with spironolactone.